illustrated that TRAIL could be produced by CAR-T cells after binding to antigen-positive tumor cells, and the clearance of antigen-negative tumor cells has been previously exposed to a low dose of local or systemic radiation. This evidence concerns the gene TNFSF10 and neoplasm.